title: Pro:  the contemporary use of transvaginal mesh in surgery for pelvic organ prolapse.
abstract: OBJECTIVE
  This review will focus on the strengths of transvaginal mesh-augmented repairs over traditional native tissue repairs with an emphasis on the more recent literature.
  
  
  RESULTS
  Recent attention from the Food and Drug Administration has prompted a re-evaluation of the use of commercial mesh kits in pelvic organ prolapse (POP) repair. Mesh kits for POP repair were recently reclassified from Class 2 medical devices to Class 3 medical devices, a policy change that will prompt additional trials for POP repair in the future. The statements published by the FDA and the reclassification of mesh kits have generated a debate regarding the use of mesh in POP repairs.
  
  
  CONCLUSIONS
  Higher complication rates involving mesh exposures have been documented in the past leading to the recent controversy; however, current mesh studies with longer term follow-up show lower and acceptable exposures with improved objective and subjective outcomes.
authors.affiliation: Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. krlinr@ccf.org
authors.forename: Ryan M
authors.initials: RM
authors.lastname: Krlin
authors.forename: Alana M
authors.initials: AM
authors.lastname: Murphy
authors.forename: Howard B
authors.initials: HB
authors.lastname: Goldman
mesh_terms: D005260:Female; D013509:Gynecologic Surgical Procedures / Q000295:instrumentation*; D006801:Humans; D056887:Pelvic Organ Prolapse / Q000601:surgery*; D013526:Surgical Mesh; D014621:Vagina / Q000601:surgery*